2179 — Jiangsu Recbio Technology Co Share Price
0.000.00%
Last trade - 00:00- HK$4.37bn
- HK$4.09bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.78 | ||
| Price to Tang. Book | 3.96 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -32.08% | ||
| Return on Equity | -41.85% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | n/a | n/a | n/a | n/a | 45.01 | 425.09 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 18th, 2012
- Public Since
- March 31st, 2022
- No. of Employees
- 472
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 479,152,000
- Address
- Vaccine Engineering Center, TAIZHOU
- Web
- https://www.recbio.cn/
- Phone
- +86 52386818860
- Auditors
- Ernst & Young
Upcoming Events for 2179
Jiangsu Recbio Technology Co Ltd Annual Shareholders Meeting
Similar to 2179
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Jiangsu Recbio Technology Co share price?
As of Today at 19:18 UTC, shares in Jiangsu Recbio Technology Co are trading at HK$9.13. This share price information is delayed by 15 minutes.
How has the Jiangsu Recbio Technology Co share price performed this year?
Shares in Jiangsu Recbio Technology Co last closed at HK$9.13 and the price had moved by -28.67% over the past 365 days. In terms of relative price strength the Jiangsu Recbio Technology Co share price has underperformed the FTSE Developed Asia Pacific Index by -28.6% over the past year.
What are the analyst and broker recommendations for Jiangsu Recbio Technology Co?
The overall consensus recommendation for Jiangsu Recbio Technology Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Jiangsu Recbio Technology Co dividend yield?
Jiangsu Recbio Technology Co does not currently pay a dividend.
Does Jiangsu Recbio Technology Co pay a dividend?
Jiangsu Recbio Technology Co does not currently pay a dividend.
When does Jiangsu Recbio Technology Co next pay dividends?
Jiangsu Recbio Technology Co does not currently pay a dividend.
How do I buy Jiangsu Recbio Technology Co shares?
To buy shares in Jiangsu Recbio Technology Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Jiangsu Recbio Technology Co?
As of the previous close price of HK$9.13, shares in Jiangsu Recbio Technology Co had a market capitalisation of HK$4.37bn.
Where are Jiangsu Recbio Technology Co shares listed?
Here are the trading details for Jiangsu Recbio Technology Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2179
What kind of share is Jiangsu Recbio Technology Co?
Based on an overall assessment of its quality, value and momentum Jiangsu Recbio Technology Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Jiangsu Recbio Technology Co share price forecast for 2024?
The analyst consensus target price for shares in Jiangsu Recbio Technology Co is HK$18.97. That is 107.74% above the last closing price of HK$9.13.
Analysts covering Jiangsu Recbio Technology Co currently have a consensus Earnings Per Share (EPS) forecast of -CNY1.19 for the next financial year.
What is the trend in the Jiangsu Recbio Technology Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jiangsu Recbio Technology Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -26.69%.
As of the last closing price of HK$9.13, shares in Jiangsu Recbio Technology Co were trading -13.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Jiangsu Recbio Technology Co PE Ratio?
The Jiangsu Recbio Technology Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$9.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Jiangsu Recbio Technology Co?
We do not have data on Jiangsu Recbio Technology Co's directors